GSK Investigational Site

Blackburn BB2 3HH

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, Type 1, Ovarian Neoplasms, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) — Stopped early
• Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 — Completed